Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite

Molecular Therapy

Volumn 11, Issue 6, 2005, Pages 960-968

  Jacquet, Alain ^a   Vanderschrick, Jean François ^a   Vandenbranden, Michel ^a   Elouahabi, Abdelatif ^a   Magi, Mauro ^a   Garcia, Lida ^a   Ruysschaert, Jean Marie ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Allergy; Cationic liposome; Challenge; diC14 amidine; Eosinophilia; IgE; ProDer p 1

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AMIDINE; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 5; LIPID; LIPOSOME; SIALIC ACID;

AEROSOL; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BINDING KINETICS; CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES; DISEASE MODEL; EOSINOPHILIA; FEMALE; HOUSE DUST ALLERGY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IONIC STRENGTH; MOUSE; NONHUMAN; PROPHYLAXIS; SPLEEN CELL; TH1 CELL; TH2 CELL;

ALLERGENS; AMIDINES; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CATIONS; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; LIPIDS; MICE; MICE, INBRED BALB C; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; TH1 CELLS; VACCINES;

ACARI; ASTIGMATA; MURINAE; PYROGLYPHIDAE;

EID: 19444371167     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.12.024     Document Type: Article

References (35)

1. T.A.E. Platt-Mills and M.D. Chapman Dust mites: Immunology, allergic disease and environmental control J. Allergy Clin. Immunol. 80 1987 755-775
2. E.R. Tovey M.D. Chapman and T.A.E. Platts-Mills Mite faeces are a major source of house dust allergens Nature 289 1981 592-593
3. S. Krillis B.A. Baldo R. Sutton and A. Basten Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus: I. Demonstration of multiple allergens by immunochemical and biologic analysis J. Allergy Clin. Immunol. 74 1984 132-141
4. O. Schulz H.F. Sewell and F. Shakib The interaction between the dust mite antigen Der p 1 and cell-signalling molecules in amplifying allergic disease Clin. Exp. Allergy 29 1999 439-444
5. A.M. Ghaemmaghami A. Robins L. Gough H.F. Sewell and F. Shakib Human T cell subset commitment determined by the intrinsic property of antigen: the proteolytic activity of the major mite allergen Der p 1 conditions T cells to produce more IL-4 and less IFN-gamma Eur. J. Immunol. 31 2001 1211-1216
6. G.A. Stewart and P.G. Holt Immunogenicity and tolerogenicity of a major house dust mite allergen, Der p I from Dermatophagoides pteronyssinus, in mice and rats Int. Arch. Allergy Appl. Immunol. 83 1987 44-51
7. Y.L. Lee C.L. Fu Y.L. Ye and B.L. Chiang Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation Scand. J. Immunol. 49 1999 229-236
8. A.H. Clarke W.R. Thomas J.M. Rolland C. Dow and R.M. O'Brien Murine allergic respiratory responses to the major house dust mite allergen Der p Int Arch. Allergy Immunol. 120 1999 126-134
9. K.G. Tournoy J.C. Kips C. Schou and R.A. Pauwels Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness Clin. Exp. Allergy 30 2000 79-85
10. C.A. Akdis and K. Blaser Bypassing IgE and targeting T cells for specific immunotherapy of allergy Trends Immunol. 22 2001 175-178
11. C. Walker and C. Zuany-Amorim New trends in immunotherapy to prevent atopic diseases Trends Pharmacol. Sci. 22 2001 84-90
12. M.D. Chapman A.M. Smith L.D. Vailes and A. Pomes Recombinant allergens for immunotherapy Allergy Asthma Proc. 23 2002 5-8
13. C. Gregoire and M.D. Chapman Recombinant allergens Clin. Rev. Allergy Immunol. 21 2001 215-227
14. M.D. Chapman A.M. Smith L.D. Vailes L.K. Arruda V. Dhanaraj and A. Pomes Recombinant allergens for diagnosis and therapy of allergic disease J. Allergy Clin. Immunol. 106 2000 409-418
15. A. Jacquet et al. Biochemical and immunological characterization of a recombinant precursor form of the house dust mite allergen Der p 1 produced by Drosophila cells Clin. Exp. Allergy 30 2000 677-684
16. M. Massaer et al. High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage Int. Arch. Allergy Immunol. 125 2001 32-43
17. M. Singh and D. O'Hagan Advances in vaccine adjuvants Nat. Biotechnol. 17 1999 1075-1081
18. R.K. Gupta Aluminium compounds as vaccine Adv. Drug Delivery Rev. 32 1998 155-172
19. M. Toda et al. Inhibition of immunoglobulin E response to Japanese cedar pollen allergen (Cry j 1) in mice by DNA immunization: Different outcomes dependent on the plasmid DNA inoculation method Immunology 99 2000 179-186
20. H.C. Yip et al. Adjuvant-guided type-1 and type-2 immunity: Infectious/ noninfectious dichotomy defines the class of response J. Immunol. 162 1999 3942-3949
21. G.L. Gustafson and M.J. Rhodes Bacterial cell wall products as adjuvants: Early interferon gamma as marker for adjuvants that enhance protective immunity Res. Immunol. 143 1992 483-488
22. C.R. Kensil Saponins as vaccine adjuvants Crit. Rev. Ther. Drug Carrier Syst. 13 1996 1-55
23. P. Moingeon J. Haensler and A. Lindberg Towards the rational design of Th1 adjuvants Vaccine 19 2001 4363-4372
24. F. Brunel A. Darbouret and J. Ronco Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine Vaccine 17 1999 2192-2203
25. T. Nakanishi et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins J. Controlled Release 61 1999 233-240
26. J.M. Ruysschaert et al. A novel cationic amphiphile for transfection of mammalian cells Biochem. Biophys. Res. Commun. 203 1994 1622-1628
27. A. El Ouahabi M. Thiry V. Pector R. Fuks J.M. Ruysschaert and M. Vandenbranden The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids FEBS Lett. 414 1997 187-192
28. L. Reyes et al. Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization Vaccine 19 2001 3778-3786
29. V. Sanchez et al. Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice: optimal prophylactic combinations are different from therapeutic ones FEMS Immunol. Med. Microbiol. 30 2001 157-165
30. R. Bei et al. The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice J. Immunother. 21 1998 159-169
31. S.C. Wu C.H. Yu C.W. Lin and I.M. Chu The domain III fragment of Japanese encephalitis virus envelope protein: Mouse immunogenicity and liposome adjuvanticity Vaccine 21 2003 2516-2522
32. X. Jiao R.Y. Wang Z. Feng H.J. Alter and J.W. Shih Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization Hepatology 37 2004 452-460
33. S. Sasaki et al. Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine Eur. J. Immunol. 27 1997 3121-3129
34. C. Foged C. Arigita A. Sundblad W. Jiskoot G. Storm and S. Frokjaer Interaction of dendritic cells with antigen-containing liposomes: Effect of bilayer composition Vaccine 22 2004 1903-1913
35. A. Jacquet M. Magi M. Haumont M. Jurado L. Garcia and A. Bollen Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1 Clin. Exp. Allergy 33 2003 218-225